前列地尔注射液治疗急性脑梗死的临床效果

Abstract
Figure/Table
References (15)
Related Citation (15)

Download: PDF (0 KB) HTML (36 KB)
Export: BibTeX | EndNote (RIS)

Abstract Objective To explore the clinical effect of Alprostadil Injection in the treatment of acute cerebral infarction.Methods A total of 100 patients with acute cerebral infarction admitted to our hospital from January 2018 to January 2019 were selected as the study objects,they were divided into the observation group and the control group according to random number table method,with 50 cases in each group.The control group treated with basic method,and the observation group treated with Alprostadil Injection on the basis of the control group.USA national institutes of health stroke scale (NIHSS) score,modified Rankin scale before stroke (mRS) score and laboratory indexes were compared before and after treatment between the two groups.The total incidence of adverse reactions were compared between the two groups.Results The NIHSS and mRS scores of the observation group were lower than those of the control group on the 15th,30th and 90th days after treatment,the differences were statistically significant (P＜0.05).The platelet aggregation rate,plasma factor Ⅷrelated antigen and tissue plasminogen activator inhibitor level in the observation group were lower than those in the control group on the 15th day after treatment,and the tissue plasminogen activator level was higher than that in the control group,the differences were statistically significant (P＜0.05).There was no significant difference in the total incidence of adverse reactions between the two groups (P＞0.05).Conclusion Alprostadil Injection can effectively improve the brain nerve function and laboratory indexes of patients with acute cerebral infarction,and does not increase the incidence of adverse reactions,which is worth clinical application.

Key words： Acute cerebral infarction Alprostadil Neurological impairment Clinical effect

	Service

	E-mail this article
	Add to my bookshelf
	Add to citation manager
	E-mail Alert
	RSS
	Articles by authors
	LIANG Xian-sheng
	XU Yi-fan
	LI Zong-hong

Cite this article:

LIANG Xian-sheng,XU Yi-fan,LI Zong-hong. Clinical effect of Alprostadil Injection in the treatment of acute cerebral infarction[J]. 中国当代医药, 2020, 27(1): 63-66.

URL:

http://dangdaiyiyao.com/EN/ OR http://dangdaiyiyao.com/EN/Y2020/V27/I1/63

[1]	虞莉娜，刘进香，席刚明.氯吡格雷联合前列地尔治疗大脑中动脉狭窄致脑梗死的临床研究[J].中国临床药理学杂志，2016，32（12）：1063-1065.
[2]	华烨，陆云南，陈萍，等.早期使用前列地尔治疗急性脑梗死的临床观察[J].中国药房，2016，27（26）：3684-3686.
[3]	程伟宁，李小林，黄龙虎，等.疏血通注射液联合前列地尔治疗急性脑梗死的临床观察[J].中国药房，2017，28（20）：2804-2807.
[4]	黄伟东，李亮，梁仕泮，等.他汀强化治疗方案在急性脑梗死患者中的应用效果[J].中国当代医药，2018，25（28）：66-69.
[5]	姜俊杰，谢雁鸣，张寅，等.基于注册登记研究的舒血宁注射液治疗脑梗死临床用药特征探析[J].中国中药杂志，2016，41（24）：4516-4520.
[6]	梁茜茜，张庆，李莉，等.阿司匹林联合氯吡格雷治疗急性脑梗死的临床研究[J].中国临床药理学杂志，2016，32（16）：1446-1448，1467.
[7]	章湉.银杏达莫注射液治疗中青年急性脑梗死的临床研究[J].中国当代医药，2018，25（1）：132-134，138.
[8]	黎明丽，宋薇，刘薇芝，等.依达拉奉联合氯吡格雷对比单用氯吡格雷治疗急性脑梗死疗效与安全性的Meta 分析[J].中国药房，2016，27（33）：4675-4678.
[9]	利伟江，罗玉媚，李光宁.尤瑞克林联合奥扎格雷钠治疗急性脑梗死的临床效果[J].中国当代医药，2018，25（34）：91-94.
[10]	廖星，张寅，谢雁鸣，等.医院集中监测7189 例脑梗死患者使用碟脉灵苦碟子注射液的真实世界用药分析[J].中国中药杂志，2016，41（23）：4442-4450.
[11]	胡英，苏静.阿加曲班联合尤瑞克林治疗急性脑梗死的临床效果[J].中国当代医药，2019，26（4）：103-106.
[12]	何国锐.丹参多酚酸配合常规治疗急性脑梗死的可行性分析[J].中国当代医药，2018，25（7）：63-65.
[13]	杜伟，庞长河，薛亚轲，等.美国神经重症监护学会《大面积脑梗死治疗指南（2015）》解读[J].中华神经医学杂志，2016，15（1）：2-5.
[14]	张静静，吕荣祥，刘郁，等.吡拉西坦注射液联合前列地尔对老年出血性脑梗死急性期患者神经功能、血管内皮功能、炎症因子和血液流变学的影响[J].中国老年学杂志，2018，38（10）：2337-2339.
[15]	张雷，陈丽波，王琳琳.前列地尔注射液治疗分水岭脑梗死的临床疗效[J].中国老年学杂志，2017，37（3）：608-609.